CARGO Therapeutics

Cargo Therapeutics is a clinical stage biotechnology company that specializes in the development of drugs against cancer.

Cargo Therapeutics, Inc. filed for an IPO to raise $300 million to develop and test drugs for the treatment of large B-cell cancer B-cell lymphoma and other B-cell malignancies.

The market for treatments for diffuse large B-cell lymphoma is expected to reach $7.9 billion by 2030, driving growth for CARGO Therapeutics.
____________________________________
Number of employees:
50 - 100
___________________________________
Headquarters:
900 Alameda De Las Pulgas, Suite 350, San Mateo, California 94403